111 Capital’s West Pharmaceutical WST Stock Holding History

111 Capital’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$619K	Buy	+1,723	New	+$527K	0.11%	195
2026 Q1	–	Sell	-1,582	Closed	-$435K	–	464
2025 Q4	$435K	Buy	+1,582	New	+$433K	0.1%	178
2025 Q3	–	Sell	-1,026	Closed	-$224K	–	710
2025 Q2	$224K	Buy	+1,026	New	+$219K	0.04%	431

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

111 Capital's WST Position: Q2 2026 in Review

111 Capital opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,723 shares worth $619K. The stake represents 0.11% of the portfolio and ranks #195 among its holdings. This is a return to the name: 111 Capital previously reported a position in WST as recently as Q4 2025.

111 Capital first reported a position in WST in Q2 2025 and has held it in 3 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

111 Capital held 1,723 shares of West Pharmaceutical worth $619K as of Q2 2026.
West Pharmaceutical was a new 111 Capital position in Q2 2026.
West Pharmaceutical made up 0.11% of 111 Capital's portfolio in Q2 2026, its #195 holding.
111 Capital first reported a position in West Pharmaceutical in Q2 2025 and has held it in 3 quarters since.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.